LGND
LIGAND PHARMACEUTICALS INC
NASDAQ · Healthcare · Biotechnology · US
$283.49
−0.43%Forward multiples
Based on analyst estimates
- P/E forward
- 27.50x
- P/E 2026E
- 30.19x
- P/E 2027E
- 23.22x
- P/E 2028E
- 19.34x
- P/S forward
- 16.76x
Trailing multiples
Trailing twelve months
- P/E TTM
- 28.32x
- PEG TTM
- 9.37x
- Price / book
- 5.84x
- Price / sales
- 19.45x
- Price / cash flow
- 42.93x
Enterprise value
- Enterprise value
- $5.4B
- EV / sales
- 18.67x
- EV / EBITDA
- 19.82x
- EV / EBIT
- 53.75x
- Market cap
- $5.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026